IGNE — Igene Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00Basic MaterialsHighly SpeculativeMicro Cap
- $0.00m
- $1.71m
- $3.96m
Annual cashflow statement for Igene Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2005 December 31st | 2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB/A | 10KSB/A | 10KSB | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.04 | -2.43 | -1.9 | -3.99 | -0.141 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.48 | 1.47 | 1.54 | 1.3 | -2.23 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.829 | 0.942 | 1.66 | 3.02 | 2.09 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | 0.29 | -0.001 | 1.31 | 0.705 | -0.097 |
| Capital Expenditures | — | 0 | -0.275 | -0.226 | -0.172 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.375 | -0.109 | -0.088 | — | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.375 | -0.109 | -0.363 | -0.226 | -0.172 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 0.011 | 0.057 | — | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.085 | -0.098 | 1 | 0.462 | -0.193 |